Apoptosis and human placenta: Expression of proteins belonging to different apoptotic pathways during pregnancy

Journal of Experimental and Clinical Cancer Research

Volumn 24, Issue 1, 2005, Pages 25-33

  De Falco, M ^a   Penta, R ^b   Laforgia, V ^a   Cobellis, L ^b   De Luca, Antonio ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Apoptosis; Immune privilege; Placenta; Syncytial fusion

Indexed keywords

CASPASE; DEATH RECEPTOR 4;

ALLOGRAFT; APOPTOSIS; ENZYME ACTIVATION; HUMAN; IMMUNE SYSTEM; INTRAUTERINE GROWTH RETARDATION; MITOCHONDRION; PLACENTA; PLACENTA DEVELOPMENT; PLACENTA FUNCTION; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR INTRINSIC ACTIVITY; REVIEW; SYNCYTIOTROPHOBLAST;

ANIMALS; APOPTOSIS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; PLACENTA; PREGNANCY; PREGNANCY PROTEINS;

EID: 18544388495     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. Jacobson M.D., Weil M., Raff M.C.: Programmed cell death in animal development. Cell 88: 347-354, 1997.
2. Huppertz B., Frank H.-G., kingdom J.C.P., Reister F., Kaufmann P.: Villous cytotrophoblast regulation of the syncytial apoptotic cascade in the human placenta. Histochem. Cell Biol. 110: 495-508, 1998.
3. Wyllie A.H.: Apoptosis. British Medical Bullettin 53. The Dorset Press, Dorchester, 1997.
4. Golstein P.: Controlling cell death. Science 275: 1081-1082, 1997.
5. Huang D.C., Hahne M., Schroeter M., Frei K., Fontana A., Villunger A., Newton K., Tschopp J., Srasser A.: Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-x(L). Prc. Natl. Acad. Sci. U.S.A. 96: 14871-14876, 1999.
6. Cain K., Bratton S.B., Cohen G.M.: The Apaf-1 apoptosome: a large caspase-activating complex. Biochimie. 84: 203-214, 2002.
7. Zou H., Yang R., Hao J., Wang J., Sun C., Fesik S.W., Wu J.C., Tomaselli K.J., Armstrong R.C.: Regulation of the Apaf-1/Caspase-9 Apoptosome by Caspase-3 and XIAP. J. Biol. Chem. 278: 8091-8098, 2003.
8. Saleh A., Srinivasula S.M., Balkir L., Robbins P.D., Alnemri E.S.: Negative regulation of the Apaf-1 apoptosome by Hsp70. Nat. Cell Biol. 2: 476-483, 2000.
9. Jiang X., Wang X.J.: Cytochrome c promotes caspase-9 activation by inducing nucleotide binding to Apaf-1. J. Biol. Chem. 275: 31199-31203, 2000.
10. Adrain C., Creagh E.M., Martin S.J.: Apoptosis-associated release of Smac/DIABLO from mitochondria requires active caspases and is blocked by Bcl-2. The EMBO Journal 20: 6627-6636, 2001.
11. Peter M.E., Krammer RH.: Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis. Curr. Opinin. Immunol. 10: 545-551, 1998.
12. Kreuz S., Siegmund D., Scheurich P., Wajant H.: NF-κB induces up-regulated cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling. Mol. Cell Biol. 21: 3964-3973, 2001.
13. Morrish D.W., Linetsky E., Bhardwaj D., Li H., Dakour J., Marsh R.G., Paterson M.C., Godbout R.: Identification by subtractive hybridization of a spectrum of novel and unexpected genes associated with in vitro differentiation of human cytotrophoblast cells. Placenta 17: 431-441, 1996.
14. Morrish D.W., Dakour J., Li H.: Life and death in the placenta: new peptides and genes regulating human syncytiotrophoblast and extravillous cytotrophoblast lineage formation and renewal. Current Protein and Peptide Science 2: 245-259, 2001.
15. Ishihara N., Matsuo H., Murakoshi H., Laoag-Fernandez J.B., Samoto T., Maruo T.: Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation. Am. J. Obstet. Gynecol. 186: 158-166, 2002.
16. Toki T., Horiuchi A., Ichikawa N., Mori A., Nikaido T., Fujii S.: Inverse relationship between apoptosis and Bcl-2 expression in syncytiotrophoblast and fibrin-type fibrinoid in early gestation. Mol. Hum. Reprod. 5: 246-251, 1999.
17. Enders A.C., Wimsatt W.A.: Formation and structure of the hemodichorial chorio-allantoic placenta of the bat (Myotis lucifungus lucifugus). Am. J. Anat. 122: 453-489, 1968.
18. Kurman R.J., Main C.S., Chen H.C.: Intermediate trophoblast: a distinctive form of trophoblast with specific morphological, biochemical and functional features. Placenta 5: 349-369, 1984.
19. Yeh I.T., Kurman R.J.: Functional and morphologic expressions of trophoblast. Lab. Invest. 61: 1-4, 1989.
20. Murakoshi H., Matsuo H., Laoag-Fernandez J.B., Samoto T., Maruo T.: Expression of Fas/Fas-ligand, Bcl-2 protein and apoptosis in extravillous trophoblast along invasion to the decidua in human term placenta. Endocr. J. 50: 199-207, 2003.
21. Austgulen R., Chedwick E., Vogt Isaksen C., Vatten L., Craven C.: Trophoblast apoptosis in human placenta at term as detected by expression of a cytokeratin 18 degradation product of caspase. Arch. Pathol. Lab. Med. 126: 1480-1486, 2002.
22. Huppertz B., Tews D.S., Kaufmann P.: Apoptosis and syncytial fusion in human placental trophoblast and skeletal muscle. Int. Rev. Cytol. 205: 215-253, 2001.
23. Mayhew T.M., Leach E., McGee R., Ismail W.W., Myklebust R., Lammiman M.J.: Proliferation, differentiation and apoptosis in villous trophoblast at 13-41 weeks of gestation (including observations on annulate lamellae and nuclear pore complexes). Placenta 20: 407-422, 1999.
24. Benirschke K., Kaufmann, P.: Pathology of the human placenta. In: N. Y. Springer (ed.), 1995.
25. Ratts V.S., Tao X.J., Webster C.B., Swanson P.E., Smith S.D., Brownbill P., Krajewski S., Reed J.C., Tilly J.L., Nelson D.M.: Expression of BCL-2, BAX and BAK in the trophoblast layer of the term human placenta: a unique model of apoptosis within a syncytium. Placenta 21: 361-366, 2000.
26. De Falco M., De Luca L., Acanfora R, Cavallotti I., Cottone G., Laforgia V., De Luca B., Baldi A., De Luca A.: Alteration of the Bcl-2:Bax ratio in the placenta as pregnancy proceeds. Histochem. J. 33: 421-425, 2001.
27. Uckan D., Steele A., Cherry Wang B.Y., Chamizo W., Koutsonikolis A., Gilbert-Barness E., Good R.A.: Trophoblasts express Fas ligand: a proposed mechanism for immune privilege in placenta and maternal invasion. Mol. Hum. Reprod. 3: 655-662, 1997.
28. De Falco M., Fedele V., Cobellis L., Mastrogiacomo A., Leone S., Giraldi D., De Luca B., Laforgia V., De Luca A.: Immunohistochemical distribution of proteins belonging to the receptor-mediated and to the mitochondrial pathways in human placenta during gestation. Cell Tissue Res. 2004 in press.
29. Runic R., Lockwood C.J., Ma Y., Dipasquale B., Guller S.: Expression of Fas ligand by human cytotrophoblasts: implications in placentation and fetal survival. J. Clin. Endocrinol. Metab. 81: 3119-3122, 1996.
30. Bamberger A.M., Schulte H. M., Thuneke I., Erdmann I., Bamberger C.M., Asa S.L.: Expression of the apoptosis-inducing Fas ligand (FasL) in human first and third trimester placenta and choriocarcinoma cells. J. Clin. Endocrinol. Metab. 82: 3173-3175, 1997.
31. Hammer A., Blaschitz A., Daxbock C., Walcher W., Dohr G.: Fas and Fas-ligand are expressed in the utero-placental unit of first trimester pregnancy. Am. J. Reprod. Immunol. 41: 41-51, 1999.
32. Huppertz B., Frank H-G, Reister F., Kingdom J., Korr H., Kaufmann P.: Apoptosis cascade progresses during turnover of human trophoblast: analysis of villous cytotrophoblast and syncytial fragments in vitro. Lab. Invest. 79: 1687-1702, 1999.
33. Huppertz B., Frank H-G., Kaufmann P.: Apoptosis of villous trophoblast in the human placenta. Placenta 18: A28, 1997.
34. Yasuda M., Umemura S., Osamura R.Y., Kenjo T., Tsutsumi Y: Apoptotic cells in the human endometrium and placental villi: pitfalls in applying the TUNEL method. Arch. Histol. Cytol. 58: 185-190, 1995.
35. Ratts V., Webster C., Swanson P., Nelson M.: Apoptosis in human placental trophoblast occurs in the presence or absence of fibrin matrix. Placenta 18: A47, 1997.
36. Sakuragi N., Luo M.N., Furata I., Watari H., Tsumura N., Nishiya M., Hirahatake K., Takeda N., Ohkouchi T., Ishikura H., Fujimoto S.: Bcl-2 expression and apoptosis in human trophoblast. Troph. Res. 9: 63-74, 1997.
37. Smith S.C., Baker P.N., Symonds E.M.: Placental apoptosis in normal human pregnancy. Am. J. Obstet. Gynecol. 177: 57-65, 1997.
38. Erel C.T., Dane B., Calay Z., Kaleli S., Aydinli K.: Apoptosis in the placenta of pregnancies complicated with IUGR. Int. J. Gynaecol. Obstet. 73: 229-235, 2001.
39. Leung D.N., Smith S.C., To K.F., Sahota D.S., Baker P.N.: Increased placental apoptosis in pregnancies complicated by preeclampsia. Am. J. Obstet. Gynecol. 184: 1249-1250, 2001.
40. Levy R., Smith S.D., Yusuf K., Huettner P.C., Kraus F.T., Sadovsky Y., Nelson D.M.: Trophoblast apoptosis from pregnancies complicated by fetal growth restriction is associated with enhanced p53 expression. Am. J. Obstet. Gynecol. 186: 1056-1061, 2002.
41. Erlebacher A.: Why isn't the fetus rejected? Curr. Opin. Immunol. 13: 590-593, 2001.
42. Hunt J.S., Vassmer D., Ferguson T.A., Miller L.: Fas ligand is positioned in mouse uterus and placenta to prevent trafficking of activated leukocytes between the mother and the conceptus. J. Immunol. 158: 4122-4128, 1997.
43. Guller S., LaChapelle L.: The role of placental Fas ligand in maintaining immune privilege at maternal-fetal interfaces. Semin. Reprod. Endocrinol. 17: 39-44, 1999.
44. Payne S.G., Smith S.C., Davidge S.T., Baker P.M., Guilbert L.J.: Death receptor Fas/Apo-1/CD95 expressed by human placental cytotrophoblasts does not mediate apoptosis. Biol. Reprod. 60: 1144-1150, 1999.
45. Jerzak M., Bischof P.: Apoptosis in the first trimester human placenta: the role in maintaining immune privilege at the maternal-fetal interface and in the trophoblast remodelling. Eur. J. Obstet. Gynecol. Reprod. Biol. 100: 138-142, 2002.
46. Abrahams V.M., Straszewski-Chavez S.L., Guller S., Mor G.: First trimester trophoblast cells secrete Fas ligand which induces immune cell apoptosis. Mol. Hum. Reprod. 10: 55-63, 2004.
47. Kang S.M., Hoffmann A., Le D., Springer M.L., Stock P.G., Blau H.M.: Immune response and myoblasts that express Fas ligand. Science 278: 1322-1324, 1997.
48. Chen J.J., Sun Y., G.J. N.: Regulation of the proinflammatory effects of Fas ligand (CD95L). Science 282: 1714-1717, 1998.
49. Shudo K., Kinoshita K., Imamura R., Fan H., Hasumoto K., Tanaka M., Nagata S., Suda T.: The membrane-bound but not the soluble form of human Fas ligand is responsible for its inflammatory activity. Eur. J. Immunol. 31: 2504-2511, 2001.
50. Gregory M.S., Repp A.C., Holhbaum A.M., Saff R.R., Marshak-Rothstein A., Ksander B.R.: Membrane Fas ligand activates innate immunity and terminates ocular immune privilege. J. Immunol. 169: 2727-2735, 2002.
51. Phillips T.A., Ni J., Pan G., Ruben S.M., Wei Y.F., Pace J.L., Hunt J.S.: TRAIL (Apo-2L) and TRAIL receptors in human placentas: implications for immune privilege. J. Immunol. 162: 6053-6059, 1999.
52. Chen L., Liu X., Zhu Y., Cao Y., Sun L., Jin B.: Localization and variation of TRAIL and its receptors in human placenta during gestation. Life Sci. 74: 1479-1486, 2004.
53. Marsters S.A., Sheridan J.P., Pitti R.M., Huang A., Skubatch M., Baldwin D., Yuan J., Gurney A., Goddard A.D., Godowski P., Ashkenazi A.: A novel receptor for Apo2L/TRAIL contains a truncated death domain. Curr. Biol. 7: 1003-1006, 1997.